| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/28/1999 | EP0910647A1 Human dnase i hyperactive variants |
| 04/28/1999 | EP0910646A1 Brain glycogen phosphorylase cancer antigen |
| 04/28/1999 | EP0910645A1 A KINASE CAPABLE OF SITE-SPECIFIC PHOSPHORYLATION OF I-kappa-B-alpha |
| 04/28/1999 | EP0910644A1 Retinoid metabolizing protein |
| 04/28/1999 | EP0910641A1 Neural cell adhesion molecule splicing variants |
| 04/28/1999 | EP0910640A2 Peptides and peptidomimetic compounds affecting the activity of g-protein-coupled receptors by altering receptor oligomerization |
| 04/28/1999 | EP0910639A1 HUMAN cAMP-DEPENDENT PROTEIN KINASE INHIBITOR HOMOLOG |
| 04/28/1999 | EP0910638A2 Polynucleotide encoding secreted proteins |
| 04/28/1999 | EP0910637A1 Polynucleotide encoding secreted protein isolated from human dendritic cells |
| 04/28/1999 | EP0910636A1 Human b-cell antigens, related reagents |
| 04/28/1999 | EP0910635A1 Hematopoietic cytokine receptor |
| 04/28/1999 | EP0910634A2 ANTISENSE INHIBITORS OF VASCULAR ENDOTHELIAL GROWTH FACTOR (VEgF/VPF) EXPRESSION |
| 04/28/1999 | EP0910629A1 Process for producing prothrombin as a basic antidote substance for natural and synthetic thrombin inhibitors |
| 04/28/1999 | EP0910628A1 Inactivation resistant factor viii |
| 04/28/1999 | EP0910583A1 Thrombin inhibitors |
| 04/28/1999 | EP0910582A1 Cell adhesion inhibiting compounds |
| 04/28/1999 | EP0910580A1 Modified factor vii |
| 04/28/1999 | EP0910579A1 Compounds with growth hormone releasing properties |
| 04/28/1999 | EP0910578A2 Recombinant expression of proteins from secretory cell lines |
| 04/28/1999 | EP0910577A2 Hypertonia gene |
| 04/28/1999 | EP0910572A1 Inhibitors of picornavirus 3c proteases and methods for their use and preparation |
| 04/28/1999 | EP0910571A2 Novel antiangiogenic peptides, polypeptides encoding same and methods for inhibiting angiogenesis |
| 04/28/1999 | EP0910569A1 Extracellular/epidermal growth factor-like protein |
| 04/28/1999 | EP0910416A2 Radiopharmaceutical compositions capable of localizing at sites of thrombus |
| 04/28/1999 | EP0910413A2 TREATMENT OF ASTHMA WITH TNFR-Ig |
| 04/28/1999 | EP0910411A1 Hydrophobic preparations containing medium chain monoglycerides |
| 04/28/1999 | EP0910408A1 DELIVERY SYSTEM USING mAb 3E10 AND MUTANTS AND/OR FUNCTIONAL FRAGMENTS THEREOF |
| 04/28/1999 | EP0910402A1 Insulin preparations containing carbohydrates |
| 04/28/1999 | EP0910401A1 Compounds that inhibit the binding of raf-1 or 14-3-3 proteins to the beta chain of il-2 receptor, and pharmaceutical compositions containing same |
| 04/28/1999 | EP0910400A1 Therapies for chronic renal failure |
| 04/28/1999 | EP0910399A1 Stable pharmaceutical composition of bdnf |
| 04/28/1999 | EP0910398A1 Method of stimulating cilia |
| 04/28/1999 | EP0910397A1 Vascular irrigation solution and method for inhibition of pain, inflammation, spasm and restenosis |
| 04/28/1999 | EP0910396A1 Isolated, nucleic acid molecules which code for gage tumor rejection antigen, the tumor rejection antigen, and uses thereof |
| 04/28/1999 | EP0910389A1 Method of promoting bone growth with hyaluronic acid and growth factors |
| 04/28/1999 | EP0910387A1 Apoptosis associated protein bbk |
| 04/28/1999 | EP0910385A1 Sensitization of cells to radiation and chemotherapy |
| 04/28/1999 | EP0910375A1 A composition of enalapril and losartan |
| 04/28/1999 | EP0910342A1 Temperature sensitive gel for sustained delivery of protein drugs |
| 04/28/1999 | EP0910340A1 Functionalized nanotubes |
| 04/28/1999 | EP0910246A1 Use of mutant alkyltransferases for gene therapy to protect from toxicity of therapeutic alkylating agents |
| 04/28/1999 | EP0789705A4 Sequence encoding mammalian sulfonylurea receptor and method of detecting persistent hyperinsulinemic hypoglycemia of infancy |
| 04/28/1999 | EP0784629B1 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteases |
| 04/28/1999 | EP0753010A4 A novel expression-cloning method for identifying target proteins for eukaryotic tyrosine kinases and novel target proteins |
| 04/28/1999 | EP0723555A4 Chimeric proteins which block complement activation |
| 04/28/1999 | EP0679092B1 Cytokine restraining agents |
| 04/28/1999 | EP0625991B1 Improved alpha interferon composition and method for its production from human peripheral blood leukocytes |
| 04/28/1999 | EP0592480B1 Use of papillomavirus L2 protein for therapeutic treatment of papillomavirus tumours or lesions |
| 04/28/1999 | EP0494268B2 Method for inhibiting growth of stem cells |
| 04/28/1999 | EP0456766B1 TYPE oc PLATELET-DERIVED GROWTH FACTOR RECEPTOR GENE |
| 04/28/1999 | EP0295248B2 Liposome preparation and antibiotic |
| 04/28/1999 | CN1215431A Genomic nucleic acids, cDNA and mDNA which code for polypeptides with IL-16 activity, processes for the production thereof and their use |
| 04/28/1999 | CN1215407A Human antibodies that bind huma TNF 'alpha' |
| 04/28/1999 | CN1215405A Use of a pharmaceutical composition comprising an appetite-suppressing peptide |
| 04/28/1999 | CN1215404A Non-dendritic backbone piptide carrier |
| 04/28/1999 | CN1215340A Composition comprising interleukin-1 inhibitor and controlled release polymer |
| 04/28/1999 | CN1215338A Pharmaceutical combination containing a compound having angiotensin II and antagonisti activity |
| 04/28/1999 | CN1215311A Diabetic supplement bar |
| 04/28/1999 | CN1215310A Method of killing or inhibiting microbial cells |
| 04/28/1999 | CN1215309A Implantable agarose-collagen beads containing cells which produce a diffusible biological product, and uses thereof |
| 04/28/1999 | CN1215084A Productive technology for A type botulism crystalline toxin and frozen-dried protective liquid needed for producing said toxin |
| 04/28/1999 | CN1215058A Novel trichain formed eliyonucleotide structure and application to anti-virus of hepatitis B |
| 04/28/1999 | CA2248274A1 Novel dbpa |
| 04/28/1999 | CA2248270A1 Novel dbpb |
| 04/27/1999 | US5898792 Methods and devices for automatic assessment of corn |
| 04/27/1999 | US5898066 Trophic factors for central nervous system regeneration |
| 04/27/1999 | US5898031 Oligoribonucleotides for cleaving RNA |
| 04/27/1999 | US5898030 hGH containing pharmaceutical compositions |
| 04/27/1999 | US5898029 Promoting sensitivity of neuronal cell systems to neurotrophic factors by the immunophilin ligands for therapeutic application in diseases involving neural degeneration, nerve damage by physical injury |
| 04/27/1999 | US5898028 An antidiabetic agent in the form of powder suitable for pulmonary administeration comprises particles of insulin or derivative, an enhancer for insulin absorption is selected from fatty acid salt, bile salt, and a phospholipid |
| 04/27/1999 | US5897862 Immuno-stimulatory monoclonal antibodies |
| 04/27/1999 | US5897860 Hemostatic composition; treating ulcers, suturing blood vessels, treating hemophilia, inhibiting growth of microrganisms |
| 04/27/1999 | CA2248119A1 Novel apt |
| 04/27/1999 | CA2248116A1 Novel muty |
| 04/27/1999 | CA2122246C Phospholipid antimicrobial compositions |
| 04/27/1999 | CA2107329C Anti-human immunodeficiency virus recombinant antibodies |
| 04/27/1999 | CA2083826C Protein having cytokine type activity, recombinant dna coding for this protein, transformed cells and microorganisms |
| 04/27/1999 | CA2064585C Inhibition of tumor growth by blockade of the protein c system |
| 04/27/1999 | CA2059523C Pharmaceutical compositions |
| 04/27/1999 | CA1340512C Expression of factor vii and ix activities in mammalian cells |
| 04/24/1999 | CA2248170A1 A clone hwhhj20 |
| 04/24/1999 | CA2224066A1 Peptides as analgesics |
| 04/24/1999 | CA2219437A1 Peptides as analgesics |
| 04/24/1999 | CA2219299A1 P-40, a new member of the multidrug resistance gene family |
| 04/23/1999 | CA2245997A1 Novel compounds |
| 04/23/1999 | CA2239255A1 Cdna clone hneaa81 that encodes a human 7-transmembrane receptor |
| 04/22/1999 | WO1999019502A1 Transfection system for the transfer of nucleic acids into cells |
| 04/22/1999 | WO1999019496A1 Inhibition of human immunodeficiency virus (hiv-1) replication |
| 04/22/1999 | WO1999019495A1 Phosphodiesterase 8a |
| 04/22/1999 | WO1999019494A1 Human ribonuclease a with reduced ribonuclease inhibitor affinity |
| 04/22/1999 | WO1999019491A2 Human dnax interleukin-40 (dil-40) |
| 04/22/1999 | WO1999019490A1 Apo-3 ligand |
| 04/22/1999 | WO1999019489A1 MYOSIN IXa AND CYCLIC NUCLEOTIDE GATED CHANNEL-15 (CNGC-15) POLYNUCLEOTIDES, POLYPEPTIDES, COMPOSITIONS, METHODS AND USES THEREOF |
| 04/22/1999 | WO1999019488A1 Novel human egf receptors and use thereof |
| 04/22/1999 | WO1999019487A1 Mammoglobin homolog |
| 04/22/1999 | WO1999019486A1 Cell division regulators |
| 04/22/1999 | WO1999019485A1 THYMOSIN β15 PROMOTER AND USE THEREOF |
| 04/22/1999 | WO1999019484A1 T cell receptor-associated molecules (trams) and methods of use therefor |
| 04/22/1999 | WO1999019483A1 Human progesterone receptor complex p23-like protein |
| 04/22/1999 | WO1999019480A2 Human receptor proteins; related reagents and methods |